TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 20:00
TG Therapeutics Total Assets (Quarterly) : 1.640B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.640B |
| March 31, 2026 | 1.529B |
| December 31, 2025 | 1.063B |
| September 30, 2025 | 1.025B |
| June 30, 2025 | 702.61M |
| March 31, 2025 | 656.69M |
| December 31, 2024 | 577.69M |
| September 30, 2024 | 586.01M |
| June 30, 2024 | 401.21M |
| March 31, 2024 | 373.32M |
| December 31, 2023 | 329.59M |
| September 30, 2023 | 331.07M |
| June 30, 2023 | 220.85M |
| March 31, 2023 | 197.36M |
| December 31, 2022 | 193.57M |
| September 30, 2022 | 217.89M |
| June 30, 2022 | 251.67M |
| March 31, 2022 | 303.03M |
| December 31, 2021 | 379.63M |
| September 30, 2021 | 409.69M |
| June 30, 2021 | 481.40M |
| March 31, 2021 | 548.70M |
| December 31, 2020 | 625.64M |
| September 30, 2020 | 273.86M |
| June 30, 2020 | 294.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 101.85M |
| December 31, 2019 | 163.01M |
| September 30, 2019 | 93.33M |
| June 30, 2019 | 106.58M |
| March 31, 2019 | 117.54M |
| December 31, 2018 | 83.62M |
| September 30, 2018 | 114.37M |
| June 30, 2018 | 140.72M |
| March 31, 2018 | 120.99M |
| December 31, 2017 | 97.38M |
| September 30, 2017 | 101.78M |
| June 30, 2017 | 101.20M |
| March 31, 2017 | 123.26M |
| December 31, 2016 | 54.78M |
| September 30, 2016 | 75.69M |
| June 30, 2016 | 94.80M |
| March 31, 2016 | 100.06M |
| December 31, 2015 | 113.47M |
| September 30, 2015 | 127.41M |
| June 30, 2015 | 123.61M |
| March 31, 2015 | 117.27M |
| December 31, 2014 | 86.75M |
| September 30, 2014 | 77.54M |
| June 30, 2014 | 56.30M |
| March 31, 2014 | 58.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.501B |
| MAIA Biotechnology, Inc. | 28.24M |
| Vericel Corp. | 502.87M |
| Incyte Corp. | 7.873B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.036B |
| Shareholders Equity (Quarterly) | 604.08M |
| Debt to Equity Ratio | 1.249 |
| Current Ratio | 4.267 |
| Net Debt Paydown Yield | -1.19% |